Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AA4500 concurrent two-injection study in Dupuytren's contracture
ACTRN12610001045000Phase 3Completed
- Sponsor
- Auxilium Phamaceuticals, Inc.
- Start
- Dec 2010
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of collagenase clostridium histolyticum in Dupuytren's contracture, sponsored by Auxilium Phamaceuticals, Inc. Primary endpoints: Safety, Tolerability and 1 more. Started Dec 2010; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
Dupuytren's contracture
Beyond the preview
Go deeper on ACTRN12610001045000.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610001045000.